{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:40:08Z","timestamp":1767706808806,"version":"3.37.3"},"reference-count":19,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Emerg Med J"],"accepted":{"date-parts":[[2019,10,3]]},"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Dextrose is commonly administered with insulin during the management of hyperkalaemia to avoid hypoglycaemia. Previous research has evaluated the incidence of hypoglycaemia; however, none have reported the extent of blood glucose reduction after this regimen. The aim of this study was to better characterise the changes in blood glucose and to identify patients who may have an increased response to insulin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a multicentre retrospective study evaluating adult patients who received a regimen of 10 units of intravenous regular insulin plus 25 g of intravenous dextrose to manage hyperkalaemia between January 2014 and September 2016. The primary outcome was to evaluate the extent of blood glucose reduction (milligram per decilitre) up to 6\u2009hours following the above regimen. Secondary outcomes included incidence of hypoglycaemia (blood glucose &lt;70\u2009mg\/dL) and severe hypoglycaemia (blood glucose &lt;40\u2009mg\/dL), and predictors of the extent of blood glucose reduction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 90 patients were included. The median blood glucose change over 6\u2009hours was \u221224\u2009mg\/dL (IQR \u221253 to 6\u2009mg\/dL). Hypoglycaemia developed in 20 patients (22.2%, 95%\u2009CI 14.1% to 32.2%) and five patients (5.6%, 95%\u2009CI 1.8% to 12.5%) had severe hypoglycaemia. Patients who developed hypoglycaemia had a median baseline blood glucose of 110\u2009mg\/dL (IQR 80 to 127\u2009mg\/dL), which decreased to a median value of 52\u2009mg\/dL (IQR 40 to 60\u2009mg\/dL). Higher baseline blood glucose was significantly associated with greater blood glucose reduction (coefficient \u22120.36, 95%\u2009CI \u22120.55 to \u22120.18, p&lt;0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The extent of blood glucose reduction is variable and hypoglycaemia is common. The high incidence of hypoglycaemia highlights the importance of frequent blood glucose monitoring.<\/jats:p><\/jats:sec>","DOI":"10.1136\/emermed-2019-208744","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T21:34:30Z","timestamp":1572039270000},"page":"31-35","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Blood glucose reduction in patients treated with insulin and dextrose for hyperkalaemia"],"prefix":"10.1136","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7049-9826","authenticated-orcid":false,"given":"Ahmed","family":"Aljabri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Perona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohannad","family":"Alshibani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moteb","family":"Khobrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Jarrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad E","family":"Patanwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"2024052709241473000_37.1.31.1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007135517950"},{"key":"2024052709241473000_37.1.31.2","first-page":"121","article-title":"Part 10.1: life-threatening electrolyte abnormalities","volume":"112","year":"2005","journal-title":"Circulation"},{"key":"2024052709241473000_37.1.31.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.971069"},{"key":"2024052709241473000_37.1.31.4","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.64.747.30"},{"key":"2024052709241473000_37.1.31.5","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.977"},{"key":"2024052709241473000_37.1.31.6","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1990.284"},{"key":"2024052709241473000_37.1.31.7","doi-asserted-by":"publisher","DOI":"10.3109\/08860229309065576"},{"key":"2024052709241473000_37.1.31.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(88)80086-X"},{"key":"2024052709241473000_37.1.31.9","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfu026"},{"key":"2024052709241473000_37.1.31.10","doi-asserted-by":"publisher","DOI":"10.1177\/1060028015607559"},{"key":"2024052709241473000_37.1.31.11","first-page":"1","article-title":"Evaluation of hypoglycemia incidence and risk factors in patients treated with IV insulin aspart for hyperkalemia","volume":"3","author":"Estep","year":"2015","journal-title":"Enocrinal Diabetes Res"},{"key":"2024052709241473000_37.1.31.12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jhm.2545","article-title":"Weight-based insulin dosing for acute hyperkalemia results in less hypoglycemia","volume":"11","author":"Wheeler","year":"2016","journal-title":"J Hosp Med"},{"key":"2024052709241473000_37.1.31.13","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1177\/1062860618764610","article-title":"Assessing the impact of an order panel utilizing weight-based insulin and standardized monitoring of blood glucose for patients with hyperkalemia","volume":"33","author":"Brown","year":"2018","journal-title":"Am J Med Qual"},{"key":"2024052709241473000_37.1.31.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2024052709241473000_37.1.31.15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/2042098618768725","article-title":"Impact of dextrose dose on hypoglycemia development following treatment of hyperkalemia","volume":"9","author":"Farina","year":"2018","journal-title":"Ther Adv Drug Saf"},{"key":"2024052709241473000_37.1.31.16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ajem.2018.05.016","article-title":"Hypoglycemia as a complication of intravenous insulin to treat hyperkalemia in the emergency department","volume":"37","author":"Scott","year":"2019","journal-title":"Am J Emerg Med"},{"key":"2024052709241473000_37.1.31.17","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/phar.2038","article-title":"A comparison of insulin doses for the treatment of hyperkalemia in patients with renal insufficiency","volume":"37","author":"LaRue","year":"2017","journal-title":"Pharmacotherapy"},{"key":"2024052709241473000_37.1.31.18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ekir.2017.10.009","article-title":"Treatment of hyperkalemia with a low-dose insulin protocol is effective and results in reduced hypoglycemia","volume":"3","author":"McNicholas","year":"2018","journal-title":"Kidney Int Rep"},{"key":"2024052709241473000_37.1.31.19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172961","article-title":"Hypoglycemia following intravenous insulin plus glucose for hyperkalemia in patients with impaired renal function","volume":"12","author":"Coca","year":"2017","journal-title":"PLoS One"}],"container-title":["Emergency Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/emermed-2019-208744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T16:24:33Z","timestamp":1716827073000},"score":1,"resource":{"primary":{"URL":"https:\/\/emj.bmj.com\/lookup\/doi\/10.1136\/emermed-2019-208744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12,17]]},"published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1136\/emermed-2019-208744"],"URL":"https:\/\/doi.org\/10.1136\/emermed-2019-208744","relation":{},"ISSN":["1472-0205","1472-0213"],"issn-type":[{"type":"print","value":"1472-0205"},{"type":"electronic","value":"1472-0213"}],"subject":[],"published":{"date-parts":[[2019,10,25]]}}}